Home›People›Paul LaViolette
PL

Paul LaViolette

Director at SpectraWAVE. Also a director at CSA Medical, Corvia Medical and CardioFocus.

ExecutiveDirectorRoles at 4 startups
Updated Nov 10, 2026·Latest SEC filing Jul 23, 2026·Suggest an edit

About Paul LaViolette

Form D filings for SpectraWAVE in 2024 list Paul LaViolette as director.

Form D filings also name Paul LaViolette as a director at CSA Medical, Corvia Medical and CardioFocus.

Paul LaViolette first appears on SEC filings in 2011.

Experience

This experience comes from Paul LaViolette's profile and from SEC filings. For roles taken from filings, the years are when the filings name Paul LaViolette in the role, so the role may have started earlier or lasted longer.

SpectraWAVE, Inc. Current
Chairman
2024 – Present · Bedford, MA
Pulse Biosciences, Inc. Current
CEO and Co-Chairman
2024 – Present
Vibrato Medical, Inc. Current
Director
2022 – Present
Deerfield Catalyst Current
Director
2022 – Present
Medtech Convergence Fund Current
Managing Partner
2020 – Present
Edwards Lifesciences Current
Director
2020 – Present
Mass General Brigham Innovation Current
Chairman
2016 – Present
CSA Medical, Inc. Current
Director
2014 – Present · Lexington, MA
Develops a liquid nitrogen treatment device for people with chronic bronchitis.
Corvia Medical, Inc. Current
Chairman
2012 – Present · Tewksbury, MA
Medical Device Manufacturers Association (MDMA) Current
Director, Past Chairman
2012 – Present
SV Health Investors Current
Managing Partner & Chief Operating Officer
2008 – Present
Zerigo Health
Director
2019 – 2024
Endotronix
Chairman
2017 – 2024
CardioFocus, Inc.
Chairman
2011 – 2022 · Marlborough, MA
Stimwave
Chairman
2019 – 2022
Misonix
Past Chairman
2020 – 2021
Bardy Diagnostics, Inc.
Past Lead Director
2017 – 2021
Ximedica
Past Chairman
2014 – 2021
Asensus Surgical
Chairman
2013 – 2021
Boston Scientific
COO
1994 – 2008

Key Colleagues at Startups

The people Paul LaViolette works with at each company, as listed on that company's latest Form D.

CSA Medical, Inc. · Form D, Jul 23, 2026
WM
Wendelin Maners
President and CEO, director
SC
Sean Cheng
Director
VO
Vincent Owens
Executive officer and director
DM
Deng Mao
Director
LD
Luc Marengere, Ph.D.
Managing Partner and director
Corvia Medical, Inc. · Form D, Jun 25, 2025
KG
Kevin Gillis
Director
GB
Gerald Brunk
Director
GF
George Fazio
Chief Executive Officer and director
DC
Dan Curtis
Executive officer
IY
Irit Yaniv
Director
SpectraWAVE, Inc. · Form D/A, Oct 15, 2024
EN
Eman Namati
CEO and director
GB
Gerry Brunk
Director
BL
Bill Little
Director
Brian Smith
Brian Smith
Director
CardioFocus, Inc. · Form D, Apr 12, 2022
SO
Stephan Ogilvie
Executive officer
CL
BR
OA
Omar Amirana
Director
BB
Burke Barrett
CEO & President, director

Sources

  1. SECCSA Medical, Inc. Form D, filed Jul 23, 2026
  2. SECCorvia Medical, Inc. Form D, filed Jun 25, 2025
  3. SECSpectraWAVE, Inc. Form D/A, filed Oct 15, 2024
  4. SECCardioFocus, Inc. Form D, filed Apr 12, 2022